Consensus Document
Tables of Specification
Syllabus, Internal Assessment
and Marking Schemes
Department of General Medicine
Fatima Jinnah Medical University
Lahore
Prof. Dr. Tahira Murtaza Cheema Prof. Dr. Bilquis Shabbir Associate Prof. Dr Tahir Bashir
(Unit-I) (Unit-II) (Unit-III)
FJMU GENERAL MEDICINE MARKING SCHEME
TOTAL MARKS = 600
THEORY INTERNAL CLINICALS INTERNAL
ASSESSMENT ASSESSMENT
SAQ MCQ OSCE LONG SHORT
CASE CASE
MEDICINE 13 X 5 65 X 1 14 X 5 100 X 1 25 X 4
I 30 40
65 65 70 100 100
MEDICINE 13 X 5 65 X 1
II
65 65
130 130
TOTAL 260+30 = 290 270 + 40 = 310
(Total marks of internal assessment = 70 )11.67%)
COMPULSORY TO SCORE 50% IN 3 COMPONENTS SEPARATELY
THEORY = INTERNAL CLINICALS (LONG CASE + SHORT CLINICALS + OSCE + INTERNAL
ASSESSMENT CASE) ASSESSMENT
(260 = 30 = 290) (100+100 = 200) (200 + 70 + 40 = 310)
PAPER I = 130
PAPER II = 130 Pass Marks in Clinicals = 100 Pass Marks = 155
PASS MARKS IN THEORY
130 = 15 = 145
MARKING SCHEME FOR THEORY, CLINICALS AND INTERNAL ASSESSMENT
Theory SEQs Marks MCQs Total Internal Assessment Grand
Lecture Attendance, Class Assessments, Send up Total
Paper I 13 65 65 130 Third Fourth Final *Class Send up
year year year Assessments
Paper II 13 65 65 130 3x3=9 2x3=6 3x3=9 1.5x3 = 4.5 1.5
Marks 260 30 290
*0.5 Marks for Assessments in each year (3rd, 4th, final) for each unit
Clinical Internal Assessment Grand
(Ward Attendance and Assessments) Total
OSCE LONG SHORT Third year Fourth year Final year BLS *Skills
Case Cases Lab
5x3 = 15 2x3 = 6 5x3 = 15
1 0.6x5 = 3
Attendance = 3 Attendance = 3 Attendance = 3
Assessment = 2 Assessment = 2 Assessment = 2
(14x5) (1) (25x4)
70 100 100 40 310
st
(*0.6x5 means Marks for skill lab for five years from 1 till final year)
GUIDELINES FOR AWARDING INTERNAL ASSESSMENT MARK
Internal assessment for Class Lecture Attendance
3rd and Final Year - 75-85%=1, 85-95%=2, >95%=3
4th Year — 75-85%=0.5, 85-90%=1, 90-95%=1.5, >95%=2
Internal assessment for Class Assessments (0.5 for each year)
Two major assessments are recommended (Midterm and End-term)
Marks for each assessment = 50-65% = 0.15, 65-80%=0.3, >80%=0.5
Internal assessment for Ward Attendance
3rd and Final Year - 75-80%=1, 80-85%=1.5, 85-90%=2, 90-95%=2.5, >95%=3
4th Year — 75-85%=0.25, 85-90%=0.5, 90-95%=0.75, >95%=1
Internal assessment for Ward Assessments
3rd and Final Year (2) — Marks= 50-60%=0.5, 61-70%=1, 71-80%=1.5, >80%=2
4th Year (1) — 50-65%=0.25, 65-80%=0.5, 80-90%=0.75, >90%=1
BLS = 1
Successful completion of written and skill assessment in first attempt = 1
Successful completion of written and skill assessment in remediation attempt = 0.5
Send up Marks = 1.5
50-60%=0.25, 60-65%=0.5, 65-70%=0.75, 70-75%=1, 75-80%=1.25, > 80%=1.5
UNIT-WISE INTERNAL ASSESSMENT AWARD SCHEME FOR 3 YEARS
Class Attendance Class Test Ward Attendance Ward Assessment Tota BL Skill Sen Tota
l S s t up l
Unit
3rd 4th Fina 3rd 4th Fina 3rd 4th Fina 3rd 4th Fina
yea yea l yea yea l yea yea l yea yea l
r r year r r year r r year r r year
I 3 2 3 0.5 0.5 0.5 3 1 3 2 1 2 21.5 1 3 1.5 5.5
II 3 2 3 0.5 0.5 0.5 3 1 3 2 1 2 21.5
III 3 2 3 0.5 0.5 0.5 3 1 3 2 1 2 21.5
Tota 9 6 9 1.5 1.5 1.5 9 3 9 6 3 6 64.5 1 3 1.5 70
l
OBJECTIVELY STRUCTURED CLINICAL ASSESSMENT (OSCE)
CT Brain Imaging ECG
Instrumentals X-Ray
At least 3 stations should be interactive replacing the table viva.
Drugs GIT
Instrument Respiratory
Drugs CNS
Counselling CVS
Interactive Interactive
LIVER & HEPATO– BILLIARY
1. Jaundice
2. Ascites
3. Acute Liver Failure
4. AutoImmune Liver Disease
5. Portal Hypertension
6. Viral Hepatitis
7. Alcohol /NASH
8. Liver Tumors
9. Inherited Disordes Of Liver
10. Pregnancy & Liver
11. Cholecystitis
CARDIOVASCULAR SYSTEM
1. IHD
2. HTN
3. Heart Failure
4. Diseases Of Pericardium & Myocardium
5. Valvular Heart Disease
ENDOCRINOLOGY
CENTRAL NERVOUS SYSTEM
[Link]
Thyroid Disorders SYSTEM
1. Stroke
1. Stomach
PSYCHIATRY
2. Adernal & Esophagus
Disorders
2. Infections
Paper –ofI Brains & meninges SAQ’s MCQ’s
Anxiety Disorders Dysphagia
GERD,
1. Pituitary
3.
Achlasia,
OSCE
3. (14) Headache
1. PUB, CVS Tumors, Functional Disorders 1-2 10
2.
4. Depression
CaAPD/
Disorders
1. 4. STEMIComa
3. 2. / Seizure
Substance Respiratory
Abuse 1-2 10
CXR 2.
DIABETES Small Intestine
MELLITUS
2. 5. NSTEMI
Neuro– Inflammatory
4. 3.
SchizophreniaLiver & GIT diseases 2-3 19
1. Malabsorption,
Pleural Effusion Motility Disorder, Tumor
3. 1. Microvascular
6. Inferior
MND Wall MI Complications
4.
[Link]
Dementia CNS 1-2 10
2. 2. Large
Macrovascular
4. 7. Anterior Wall MIIntestine Complications
Tremors
5. Haematology 1-2 10
3. DERMATOLOGY
3. LobarMalignancy,
DKA Pneumonia IBD, IBS, Ischemic gut
5. 8. AtrialCerebellar
fibrillationdisorders
[Link]/m 6.
Eczema Miscellaneous 1 6
4. 4. Pancreatic
of type
6. 9. AtrialNeuropathies
Flutter – Diseases
I & II DM
2. Bullous – II & Myopathies
PaperLesions SAQ’s MCQ’s
5. RESPIRATORY
Abscess
7. HAEMATOLOGY
Complete Heart Block SYSTEM
1.
[Link]
Scabies Endocrine 1-2 10
6. Asthma
8. 1. Ventricular
Anemias Fibrillation
2.
[Link]
Psoriasis DM 1-2 5
7. COPD
9. 2. Ventricular
Bleeding Tachycardia
Disorders
5. 3.
Skin TumorsRheumatology 1-2 12
8. [Link]
Pneumonia
Stenosis
[Link] Disorders
[Link] 4.
Fungal Skin
Infections 1-2 10
9. [Link] Edema
1. 4. Increased ICP
Lympho-Proliferative Disorders
INFECTIONS 5.
[Link] Psychiatry
ILD / Occupational Diseases 1-2 10
10.
2. 5. Intracerebral Hemorrhage
Thrombotic
6. Disorders
Nephrology 1-2 10
1.6. Viral
Bronchiectasis
Infections
3. RHEUMATOLOGY
Cerebral Infarction
7.
2.7. Bacterial
Pleural Infectious
Diseases
Infections 1 8
4. 1. Meningioma
Rheumatoid Arthritis
3.8. T.B 8.
Pulmonary Miscellaneous
Hypertension 1-2 1-2
5. 2. Subdural Hematoma
SLE, Systemic Sclerosis
4. HIV / AIDS
6. 3. Epidural Hematoma
Vasculitis
5. Diarrhea
7. 4. Stroke
Gout
6. Protozoal Infections
8. 5. Hydrocephalus
Osteoarthritis
7. Fungal Infections
9. 7. Subarachnoid
Arthropathies Hemorrhage
8. Polymyositis
Emergency Medicine:
Cardiology
1. Inj. Heparin
2. Atropine
3. Adrenaline
4. Dopamine
5. Dobutamine
6. Norepinephrine
7. Aspirin
8. Clopidogrel
9. Glycerine Trinitrate
10. Isosorbide dinitrate
11. Beta Blockers (Mepressor)
12. Furosemide Injection
13. Streptokinase injection
14. Lidocaine injection
15. Captopril
Respiratory:
1. Salbutamol (Inhaler/ nebulizer)
2. Ipratropium Bromide (Inhaler/ nebulizer)
3. Beclomethasone diproprionate (Inhaler/ nebulizer)
4. Inj. Hydrocortisone
5. Inj. Chlorpheniramine
6. Inj. Magnesium sulphate/ Aminophylline tablet
Pain killer;
1. Inj. Diclofenac
2. Inj. Nalbuphine + cyclizine (marzine)
3. Paracetamol tablet
4. Inj. Morphine for pulmonary edema + metoclopromide
Antibiotics
1. Inj. coamoxiclav
2. Inj. Ampicillin
3. Inj. Cefuroxime / Cefrtiaxone / Ceftazidime
4. Inf. Ciprofloxacin / Levofloxacin / Moxifloxacin
5. Inf. Metronidazole
6. Inf. Vancomycin
CNS:
1. Inj. Diazepam
2. Inj. Phenytoin
GIT:
Drips:Inj. Octreotide ( Sandostatin)
1.
1.
2. Inf. Omeprazole
Inj. 0.9% Normal Saline 1000ml
2.
3. Inf. 5%
Tab. Dextrose Saline 1000ml
Metoclopromide
3. Inj. 25% Dextrose Water 1000ml
4. Inj. 5% Dextrose Water 1000ml
Instruments:
1. NG tube
2.
REFERENCES:
Endotracheal tube
3. Drip set
1.
4. Hutchison's ClinicalInsulin
Syringes (LP needle, Methods by 10
1cc, 5cc, Michael
cc, 60ccSwash.
with nosel)
5. (Latest Edition)
Defibrillator
2. Davidson's Principles and Practice of Medicine
6. Airways
(Latest Edition)
7. Tracheostomy Tube
3. Macleod's Clinical Examination
8. Laryngoscope
(Latest Edition)
9. I/V cannula
10. Face mask/ Oxygen mask/ nasal cannula
11. Urinary catheter (foley’s)
12. Double lumen
13. CVP line
14. Blood bag
15. Blood transfusion set
16. Opthalmoscope
17. Lumbar puncture needle
18. Sengstaken–Blakemore Tube
19. Pleural biopsy needle
20. Liver biopsy needle
21. Microburettte
22. Chest drain with underwater seal
23. Chest tube
24. Nelton drain
25. Suction bottle